Table 3 Plasma levels of the 4 cardiovascular biomarkers under study before and after PMC, in the overall population and according to procedural success
From: Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146
Whole population (N = 40) | Successful PMC (n = 30) | Unsuccessful PMC (n = 10) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Pre-PMC | Post-PMC | pvalue | Pre-PMC | Post-PMC | pvalue | Pre-PMC | Post-PMC | pvalue | |
BNP, pg/mL | 182 [80–194] | 132 [56–125] | 0.028 | 184 [63–194] | 122 [53–123] | 0.03 | 176 [87–193] | 161 [60–344] | 0.62 |
NT-proBNP, pg/mL | 1050[232–1171] | 739 [219–909] | 0.08 | 1067 [200–1171] | 654 [141–706] | 0.08 | 999 [311–1128] | 994 [375–1951] | 0.97 |
MR-proANP, nmol/mL | 220 [142–273] | 187 [130–224] | 0.0025 | 219 [142–257] | 179 [123–219] | 0.0012 | 223 [139–284] | 210 [133–347] | 0.6 |
sCD146, ng/mL | 379 [308–441] | 343[277–416] | 0.0081 | 370 [298–427] | 327 [268–378] | 0.002 | 406 [323–483] | 389 [283–555] | 0.7 |